Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

FXR1 expression domain in Wilms tumor.

Phelps HM, Pierce JM, Murphy AJ, Correa H, Qian J, Massion PP, Lovvorn HN 3rd.

J Pediatr Surg. 2019 Feb 28. pii: S0022-3468(19)30171-X. doi: 10.1016/j.jpedsurg.2019.02.030. [Epub ahead of print]

PMID:
30894247
2.

Association between image-defined risk factors and neuroblastoma outcomes.

Phelps HM, Ndolo JM, Van Arendonk KJ, Chen H, Dietrich HL, Watson KD, Hilmes MA, Chung DH, Lovvorn HN 3rd.

J Pediatr Surg. 2019 Mar 1. pii: S0022-3468(19)30181-2. doi: 10.1016/j.jpedsurg.2019.02.040. [Epub ahead of print]

PMID:
30885556
3.

Minimally Invasive Surgery in Pediatric Surgical Oncology.

Phelps HM, Lovvorn HN 3rd.

Children (Basel). 2018 Nov 26;5(12). pii: E158. doi: 10.3390/children5120158. Review.

4.

Biological Drivers of Wilms Tumor Prognosis and Treatment.

Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN 3rd.

Children (Basel). 2018 Oct 26;5(11). pii: E145. doi: 10.3390/children5110145. Review.

5.

Distinct mucosal microbial communities in infants with surgical necrotizing enterocolitis correlate with age and antibiotic exposure.

Romano-Keeler J, Shilts MH, Tovchigrechko A, Wang C, Brucker RM, Moore DJ, Fonnesbeck C, Meng S, Correa H, Lovvorn HN 3rd, Tang YW, Hooper L, Bordenstein SR, Das SR, Weitkamp JH.

PLoS One. 2018 Oct 26;13(10):e0206366. doi: 10.1371/journal.pone.0206366. eCollection 2018.

6.

Pediatric Solid Tumors in Resource-Constrained Settings: A Review of Available Evidence on Management, Outcomes, and Barriers to Care.

Carter NH, Avery AH, Libes J, Lovvorn HN 3rd, Hansen EN.

Children (Basel). 2018 Oct 23;5(11). pii: E143. doi: 10.3390/children5110143. Review.

7.

Optimising surveillance for relapse of Wilms' tumour.

Lovvorn HN 3rd.

Lancet Oncol. 2018 Aug;19(8):1006-1007. doi: 10.1016/S1470-2045(18)30440-6. Epub 2018 Jun 27. No abstract available.

PMID:
29960847
8.

Maintaining oncologic integrity with minimally invasive resection of pediatric embryonal tumors.

Phelps HM, Ayers GD, Ndolo JM, Dietrich HL, Watson KD, Hilmes MA, Lovvorn HN 3rd.

Surgery. 2018 Aug;164(2):333-343. doi: 10.1016/j.surg.2018.03.020. Epub 2018 May 8.

PMID:
29751968
9.

Improving the value of care for appendectomy through an individual surgeon-specific approach.

Robinson JR, Carter NH, Gibson C, Brinkman AS, Van Arendonk K, Speck KE, Danko ME, Jackson GP, Lovvorn HN 3rd, Blakely ML.

J Pediatr Surg. 2018 Jun;53(6):1181-1186. doi: 10.1016/j.jpedsurg.2018.02.081. Epub 2018 Mar 8.

PMID:
29605268
10.

Unique application of awake tracheoscopy and endobronchial ultrasound in the management of tracheal mucoepidermoid carcinoma.

Rehman S, Lovvorn HN 3rd, Rickman OB, Wootten CT, Chinnadurai S.

Head Neck. 2018 Jun;40(6):E58-E61. doi: 10.1002/hed.25147. Epub 2018 Mar 25.

PMID:
29575399
11.

Rapid resolution of hyperammonemia in neonates using extracorporeal membrane oxygenation as a platform to drive hemodialysis.

Robinson JR, Conroy PC, Hardison D, Hamid R, Grubb PH, Pietsch JB, Lovvorn HN 3rd.

J Perinatol. 2018 Jun;38(6):665-671. doi: 10.1038/s41372-018-0084-0. Epub 2018 Feb 21.

12.

Evolution of a level I pediatric trauma center: Changes in injury mechanisms and improved outcomes.

Schlegel C, Greeno A, Chen H, Raees MA, Collins KF, Chung DH, Lovvorn HN 3rd.

Surgery. 2018 May;163(5):1173-1177. doi: 10.1016/j.surg.2017.10.070. Epub 2018 Jan 17.

PMID:
29373171
13.

Review of 1,000 consecutive extracorporeal membrane oxygenation runs as a quality initiative.

Lovvorn HN 3rd, Hardison DC, Chen H, Westrick AC, Danko ME, Bridges BC, Walsh WF, Pietsch JB.

Surgery. 2017 Aug;162(2):385-396. doi: 10.1016/j.surg.2017.03.020. Epub 2017 May 24.

PMID:
28551379
14.

Optimizing surgical resection of the bleeding Meckel diverticulum in children.

Robinson JR, Correa H, Brinkman AS, Lovvorn HN 3rd.

J Pediatr Surg. 2017 Oct;52(10):1610-1615. doi: 10.1016/j.jpedsurg.2017.03.047. Epub 2017 Mar 23.

15.

Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.

Polosukhina D, Love HD, Correa H, Su Z, Dahlman KB, Pao W, Moses HL, Arteaga CL, Lovvorn HN 3rd, Zent R, Clark PE.

Mol Oncol. 2017 Apr;11(4):405-421. doi: 10.1002/1878-0261.12044. Epub 2017 Mar 15. Erratum in: Mol Oncol. 2019 Apr;13(4):978.

16.

Effect of a Clinical Practice Guideline for Pediatric Complicated Appendicitis.

Willis ZI, Duggan EM, Bucher BT, Pietsch JB, Milovancev M, Wharton W, Gillon J, Lovvorn HN 3rd, O'Neill JA Jr, Di Pentima MC, Blakely ML.

JAMA Surg. 2016 May 18;151(5):e160194. doi: 10.1001/jamasurg.2016.0194. Epub 2016 May 18.

17.

Genetic and chromosomal alterations in Kenyan Wilms Tumor.

Lovvorn HN 3rd, Pierce J, Libes J, Li B, Wei Q, Correa H, Gouffon J, Clark PE, Axt JR, Hansen E, Newton M, O'Neill JA Jr; Kenyan Wilms Tumor Consortium.

Genes Chromosomes Cancer. 2015 Nov;54(11):702-15. doi: 10.1002/gcc.22281. Epub 2015 Aug 14.

18.

A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor.

Yi Y, Polosukhina D, Love HD, Hembd A, Pickup M, Moses HL, Lovvorn HN 3rd, Zent R, Clark PE.

J Urol. 2015 Dec;194(6):1762-70. doi: 10.1016/j.juro.2015.04.090. Epub 2015 Apr 29.

19.

Peptide spectra in Wilms tumor that associate with adverse outcomes.

Murphy AJ, Pierce J, Seeley EH, Sullivan LM, Ruchelli ED, Nance ML, Caprioli RM, Lovvorn HN 3rd.

J Surg Res. 2015 Jun 15;196(2):332-8. doi: 10.1016/j.jss.2015.03.020. Epub 2015 Mar 18.

20.

Risk factors for abandonment of Wilms tumor therapy in Kenya.

Libes J, Oruko O, Abdallah F, Githanga J, Ndung'u J, Musimbi J, Njuguna F, Patel K, White J, Axt JR, O'Neill JA Jr, Shrubsole M, Li M, Lovvorn HN 3rd.

Pediatr Blood Cancer. 2015 Feb;62(2):252-256. doi: 10.1002/pbc.25312. Epub 2014 Nov 8.

Supplemental Content

Loading ...
Support Center